{"nct_id":"NCT05301842","title":"Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2022-03-28","start_date_type":"ACTUAL","primary_completion_date":"2025-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}